Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525

Immutep Limited announced the grant of patent no. 7030750 entitled “Antibody molecules to LAG-3 and uses thereof” by the Japanese Patent Office directed to pharmaceutical compositions for use in the treatment of cancer.